Obesity and resistant hypertension: Never ending story

No abstract is available for this paper.

• Publication year

  2019

• Venue

  The Journal of Clinical Hypertension

• Publication date

  2019-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jch.13669PMID 31448857PMCID PMC8030547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prevalence and predictors of resistant hypertension in high‐risk overweight and obese patients: A cross‐sectional study based on the 2017 ACC/AHA guidelines

  2019cited by this paper
• Weight Loss and Hypertension in Obese Subjects

  2019cited by this paper
• Sympathetic Neural Overdrive in the Obese and Overweight State.

  2019cited by this paper
• Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines

  2019cited by this paper
• A Proposed Inflammatory Score of Circulating Cytokines/Adipokines Associated with Resistant Hypertension, but Dependent on Obesity Parameters

  2019cited by this paper
• Weight Loss Medications in the Treatment of Obesity and Hypertension

  2019cited by this paper
• 2018 ESC/ESH Guidelines for the management of arterial hypertension.

  2019cited by this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cited by this paper
• Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

  2017cited by this paper
• Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

  2017cited by this paper
• Body Fatness and Cancer--Viewpoint of the IARC Working Group.

  2016cited by this paper
• Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

  2015cited by this paper
• Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.

  2015cited by this paper
• Refractory Hypertension: Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort

  2014cited by this paper
• Hypertension in the United States, 1999 to 2012: Progress Toward Healthy People 2020 Goals

  2014cited by this paper
• Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999‐2010

  2014cited by this paper
• Effect of Bariatric Surgery on Hypertension

  2014cited by this paper
• The Sympathetic Nervous System in Obesity Hypertension

  2013cited by this paper
• Midlife obesity and dementia: Meta‐analysis and adjusted forecast of dementia prevalence in the united states and china

  2013cited by this paper
• Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

  2011cited by this paper
• Obstructive sleep apnea and hypertension: Mechanisms, evaluation, and management

  2007cited by this paper
• Body Mass Index and Risk for End-Stage Renal Disease

  2006cited by this paper
• Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

  2002cited by this paper

• Temporal Trends and Disparities in Cardiovascular Mortality Among Adults With Obesity in the United States From 1999 to 2023.

  2026cites this paper
• Controversies related to renal artery denervation and devices

  2024cites this paper
• Sub-Chronic Peroneal Nerve Stimulation Lowers Ambulatory Blood Pressure in Spontaneously Hypertensive Rats

  2024influential citation
• We are all different: Modeling key individual differences in physiological systems.

  2024cites this paper
• Heart failure treatment in patients with and without obesity with an ejection fraction below 50%

  2023cites this paper
• Effects of an oral biodegradable device used for 12 weeks on weight reduction, cardiovascular risk factors, satiety, snacking, and meal size

  2023influential citation
• Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India.

  2022cites this paper
• Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J‐HOP) Study

  2021cites this paper
• ARTERİAL HİPERTENZİYA VƏ PİYLƏNMƏ OLAN XƏSTƏLƏRDƏ IRS-1 VƏ ADIPOQ GENLƏRİ POLİMORFİZMİNİN HEMODİNAMİK VƏ NEYROHUMORAL PARAMETRLƏRLƏ ƏLAQƏSİ

  year unknowncites this paper